Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its halogenated structure allows for selective cross-coupling reactions, enabling the construction of complex molecules in medicinal chemistry. Also employed in the preparation of bioactive quinoxaline derivatives with potential antimicrobial and anti-inflammatory properties. Commonly utilized in research settings for designing novel heterocyclic compounds in drug discovery programs.